Patent details

300436 Product Name: Saxagliptine, alsmede farmaceutisch aanvaardbare zouten daarvan, waaronder saxagliptine hydrochloride.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300436
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1261586
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300436
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/09/545/001-010
Marketing Authorization Type:
EEA
Marketing Authorization Date:
05/10/2009
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
17/02/2010
First Marketing Authorization date:
05/10/2009
Grant date:
10/03/2010
Activation date:
05/03/2021
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
17/02/2010
SPC/SPC Extension Expiration Date:
04/10/2024
Lapsed By Expiration Date:
05/10/2024
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
01/05/2014
 
 

 

Name:
AstraZeneca AB
Address:
-, 151 85 SÖDERTÄLJE, Sweden (SE)

Historical Applicant/holder

From:
17/02/2010
To:
01/05/2014

 

Name:
BRISTOL-MYERS SQUIBB COMPANY
Address:
345 Park Avenue, 10154, New York, New York, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
17/02/2010
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
41/24
Publication date:
09/10/2024
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
10/21
Publication date:
10/03/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
CO
Journal edition number:
2014/22
Publication date:
28/05/2014
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
SPC
Journal edition number:
2010/04
Publication date:
01/04/2010
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

5

Bulletin Heading:
SPC
Journal edition number:
2010/07
Publication date:
31/03/2010
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
021946-A021946-1
Date Registered:
01/05/2014
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
021945-A021945-1
Date Registered:
01/05/2014
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
21/02/2024
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
2200 Euro
Payer:
Arnold & Siedsma BV
Filing date Document type Document Description Number of pages File Type
31/01/2017 Outgoing Correspondence Decision grant 1 PDF /6/3/4/0/0/0400300436/docs/300436_6_outgoingcorrespondence20170201114618661.pdf
31/01/2017 SPC Documents Certificate SPC 1 PDF /6/3/4/0/0/0400300436/docs/300436_7_supplprotectioncertificate20170201114715250.pdf
04/01/2017 SPC Documents Accompanying letter SPC 2 PDF /6/3/4/0/0/0400300436/docs/300436_4_supplprotectioncertificate20200907032836540.pdf
04/01/2017 SPC Documents Mail SPC 13 PDF /6/3/4/0/0/0400300436/docs/300436_9_supplprotectioncertificate20200907033110561.pdf
04/01/2017 SPC Documents Annex SPC 10 PDF /6/3/4/0/0/0400300436/docs/300436_12_supplprotectioncertificate20200907033002729.pdf
10/03/2010 Outgoing Correspondence Outgoing Letter 1 PDF /6/3/4/0/0/0400300436/docs/300436_8_outgoingcorrespondence20100310.pdf
10/03/2010 SPC Documents Certificate SPC 1 PDF /6/3/4/0/0/0400300436/docs/300436_10_supplprotectioncertificate20200907031834423.pdf
09/03/2010 SPC Documents Accompanying letter SPC 1 PDF /6/3/4/0/0/0400300436/docs/300436_3_supplprotectioncertificate20200907031715371.pdf
18/02/2010 Outgoing Correspondence Outgoing Letter 1 PDF /6/3/4/0/0/0400300436/docs/300436_0_outgoingcorrespondence20100218.pdf
17/02/2010 SPC Documents Annex SPC 2 PDF /6/3/4/0/0/0400300436/docs/300436_1_supplprotectioncertificate20200907025526558.pdf
17/02/2010 SPC Documents Marketing Authorization SPC 4 PDF /6/3/4/0/0/0400300436/docs/300436_2_supplprotectioncertificate20200907025725289.pdf
17/02/2010 Application Form First filed application form 2 PDF /6/3/4/0/0/0400300436/docs/300436_5_applicationform20100217.pdf
17/02/2010 SPC Documents Summary of the characteristics of the product 13 PDF /6/3/4/0/0/0400300436/docs/300436_11_supplprotectioncertificate20200907025526494.pdf
17/02/2010 SPC Documents Annex SPC 13 PDF /6/3/4/0/0/0400300436/docs/300436_13_supplprotectioncertificate20200907025526618.pdf